Clinical Trials on Hepatitis C Recurrent in South Africa
Total 704 results
-
bioLytical LaboratoriesRecruiting
-
Kirby InstituteCompletedHepatitis C, ChronicAustralia
-
Kirby InstituteCompleted
-
AbbVieCompletedHepatitis C Virus (HCV)United States, Australia, Belgium, Canada, France, New Zealand, Singapore, South Africa, Vietnam
-
Kirby InstituteMerck Sharp & Dohme LLC; The University of New South WalesCompletedChronic Hepatitis C InfectionAustralia
-
Kirby InstituteCompleted
-
Bristol-Myers SquibbWithdrawnChronic Hepatitis CAustralia
-
Kirby InstituteJanssen-Cilag Ltd.CompletedHepatitis C, ChronicAustralia
-
Novartis PharmaceuticalsCompletedChronic Hepatitis C Genotype-1 RelapseBelgium, United States, Germany, Spain, Puerto Rico, Taiwan, Australia
-
Garvan Institute of Medical ResearchCompleted
-
Kirby InstituteThe University of New South WalesCompleted
-
Melbourne HealthHoffmann-La Roche; Monash University; The University of New South Wales; St Vincent... and other collaboratorsCompletedChronic Hepatitis CAustralia
-
GlaxoSmithKlineCompleted
-
Avera McKennan Hospital & University Health CenterWithdrawnChronic Hepatitis CUnited States
-
Kirby InstituteCompleted
-
Kirby InstituteBristol-Myers SquibbWithdrawnHepatitis C, ChronicAustralia
-
Kirby InstituteCompleted
-
Boehringer IngelheimWithdrawnHepatitis C, ChronicAustralia, Spain, Sweden
-
bioLytical LaboratoriesRecruitingHepatitis B | Hepatitis B InfectionSouth Africa
-
Bristol-Myers SquibbCompletedHepatitis CUnited States, Australia, Canada, France
-
Atea Pharmaceuticals, Inc.RecruitingHepatitis C | Hepatitis C, Chronic | HCV | Chronic Hepatitis C Virus | Hepatic CirrhosisTurkey, Brazil, Romania, Canada, Philippines, Pakistan, South Africa, Moldova, Republic of, United States, India, Korea, Republic of, Mauritius
-
Kirby InstituteAbbVieCompletedHepatitis C, AcuteUnited Kingdom, Australia, New Zealand
-
Alios Biopharma Inc.Vertex Pharmaceuticals IncorporatedTerminatedHepatitis C, ChronicAustralia, New Zealand
-
Finch Research and Development LLC.TerminatedRecurrent C. Difficile InfectionUnited States, Canada
-
Kirby InstituteMerck Sharp & Dohme LLCCompletedHepatitis C, ChronicAustralia, Canada, United Kingdom, Belgium, Germany, Norway, Switzerland
-
Bristol-Myers SquibbCompletedHepatitis CUnited States, Australia, Canada, France, Puerto Rico
-
Bristol-Myers SquibbPharmassetCompletedChronic Hepatitis CUnited States, Puerto Rico
-
Gilead SciencesTerminatedChronic Hepatitis CUnited States, Australia, Canada, New Zealand
-
University of Witwatersrand, South AfricaUnknownMeasles | Hepatitis A | VaricellaSouth Africa
-
Hologic, Inc.CompletedHepatitis CUnited States, Puerto Rico
-
Gilead SciencesTerminatedHepatitis C Virus InfectionUnited States, United Kingdom, Australia, Germany, Italy, New Zealand, Belgium, Poland, Russian Federation
-
AbbVieCompletedChronic Hepatitis C VirusJapan
-
Bausch Health Americas, Inc.CompletedChronic Hepatitis CUnited States, Spain, Italy, Australia, Canada, Poland, Puerto Rico, Russian Federation, Argentina, France, Israel, United Kingdom
-
Kirby InstituteRecruitingHepatitis C | Hepatitis C, ChronicAustralia
-
Kirby InstituteCompletedHepatitis C, ChronicUnited States, United Kingdom, Australia, France, New Zealand, Canada, Switzerland, Germany
-
Bristol-Myers SquibbCompletedHepatitis CArgentina, Australia, Belgium, France, Germany, Italy, United States, Canada, Spain, Mexico, Austria, Poland, Netherlands, Korea, Republic of, Puerto Rico, New Zealand, Finland, Greece, Romania
-
Bristol-Myers SquibbCompletedChronic Hepatitis CFrance, United States, Puerto Rico
-
Human Genome Sciences Inc.NovartisCompletedChronic Hepatitis CKorea, Republic of, United States, Spain, Canada, France, Australia, Israel, Singapore, Thailand, Malaysia, Sweden, Belgium, Germany, Taiwan, Poland, Argentina, India, Puerto Rico, Brazil, Mexico, United Kingdom
-
Gilead SciencesCompletedChronic Hepatitis CUnited States, Germany, Australia, United Kingdom, France, Netherlands, Canada, New Zealand, Italy, Poland, Austria, Estonia, Spain, Sweden, Puerto Rico, Czech Republic
-
Human Genome Sciences Inc.NovartisCompletedChronic Hepatitis CUnited States, Spain, Canada, France, Australia, Italy, Israel, Poland, United Kingdom, Germany, Czech Republic, Romania, Austria, India, Puerto Rico
-
Bristol-Myers SquibbCompletedHepatitis C VirusAustralia, France, United States, Spain, Italy, Netherlands, Romania, Russian Federation
-
Hoffmann-La RocheCompletedHepatitis C, ChronicUnited States, New Zealand, Germany, Australia, Poland
-
Janssen Infectious Diseases BVBAVertex Pharmaceuticals IncorporatedCompletedGenotype 1 Chronic Hepatitis C | Treatment NaiveUnited States, Australia, France, Poland, United Kingdom, Belgium, Germany, Spain, Sweden, Brazil, Austria, Ireland, Mexico
-
Hoffmann-La RocheCompletedHepatitis C, ChronicUnited States
-
GlaxoSmithKlineCompletedDiphtheria; Haemophilus Influenzae Type b; Hepatitis B; Tetanus; Whole Cell PertussisSouth Africa
-
Bristol-Myers SquibbCompletedHepatitis CAustralia, France, Germany, Italy, United Kingdom, United States, Canada, Poland, Austria, Denmark, Israel, Spain, Russian Federation, Switzerland, Argentina, Brazil
-
Gilead SciencesTerminatedHepatitis C Virus InfectionFrance, Spain, United States, Australia, Canada, Germany, United Kingdom, Italy, New Zealand, Puerto Rico
-
Kirby InstituteRecruiting
-
AbbVieCompletedChronic Hepatitis C Virus (HCV) Infection Genotype 1Algeria, Australia, Belgium, Bulgaria, Canada, Denmark, Finland, France, Germany, Greece, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Spain, Switzerland, Turkey, Austria, Ireland and more
-
Kirby InstituteCompleted